Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: TEVA PHARMACEUTICALS USA, INC.
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-12-06 to 2022-12-20
Current total value of award: $587295.72
Description: 8509568680!ADENOVIRUS TYPE 4 A